未知生产厂商
Sacrosidase is an enzyme replacement therapy used for the treatment of congenital sucrase-isomaltase deficiency (CSID).
Sacrosidase is an enzyme replacement therapy used for the treatment of congenital sucrase-isomaltase deficiency (CSID).
Sacrosidase is a [beta]-fructofuranoside fructohydrolase that hydrolyzes sucrose. Unlike human intestinal sucrase-isomaltase, it has no activity with oligosaccharides containing 1,6 glucosyl bonds.
For the treatment of congenital sucrose-isomaltase deficiency (CSID).
共 1 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
